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Abstract
Background: Human TGF-β3 has been used in many studies to induce genes coding for typical cartilage matrix
components and accelerate chondrogenic differentiation, making it the standard constituent in most cultivation
media used for the assessment of chondrogenesis associated with various stem cell types on carrier matrices.
However, in vivo data suggests that TGF-β3 and its other isoforms also induce endochondral and intramembranous
osteogenesis in non-primate species to other mammals. Based on previously demonstrated improved articular
cartilage induction by a using hTGF-β3 and hBMP-6 together on hADSC cultures and the interaction of TGF- β with
matrix in vivo, the present study investigates the interaction of a chitosan scaffold as polyanionic polysaccharide
with both growth factors. The study analyzes the difference between chondrogenic differentiation that leads to
stable hyaline cartilage and the endochondral ossification route that ends in hypertrophy by extending the usual
panel of investigated gene expression and stringent employment of quantitative PCR.
Results: By assessing the viability, proliferation, matrix formation and gene expression patterns it is shown that
hTGF-β3 + hBMP-6 promotes improved hyaline articular cartilage formation in a chitosan scaffold in which ACAN
with Col2A1 and not Col1A1 nor Col10A1 where highly expressed both at a transcriptional and translational level.
Inversely, hTGF-β3 alone tended towards endochondral bone formation showing according protein and gene
expression patterns.
Conclusion: These findings demonstrate that clinical therapies should consider using hTGF-β3 + hBMP-6 in articular
cartilage regeneration therapies as the synergistic interaction of these morphogens seems to ensure and maintain
proper hyaline articular cartilage matrix formation counteracting degeneration to fibrous tissue or ossification. These
effects are produced by interaction of the growth factors with the polysaccharide matrix.
Keywords: Chitosan, Promotion, Adipose-derived stem cell, Articular Chondrogenesis, Bone formation, hTGF-β3,
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Background
Healthy articular cartilage lacks self-repairing capacities
due to its avascular structure. This makes self-
regeneration and self-healing impossible, unlike bone,
which can lead to functional limitations and pain even-
tually associated to osteoarthritis [1–4]. Compared to
other therapies, autologous chondrocyte implantation
has emerged as a promising technique in orthopedic sur-
gery to treat cartilage defects [5–9]. However, autolo-
gous chondrocyte implantation suffers from several
limitations. Often a cartilage graft is harvested from an
articular joint, which can cause distinct donor site mor-
bidity, limiting the supply of autologous chondrocytes
[10–12]. Stem cell-based therapies are an alternative to
overcome the poor self-repair capacity of cartilage,
where, under the principle of tissue engineering, an in-
soluble substratum is combined with soluble signals
[13–15]. For cartilage regeneration, chondrocytes or
stem cells are often combined with a biomimetic
biomaterial that supports the formation of neo-cartilage
tissue with the typical characteristics of hyaline articular
cartilage [16].
Extracellular matrix-like scaffolds can provide a struc-
tural template for cartilage development and also serve
as a substrate that helps to facilitate cell attachment,
proliferation, differentiation to the desired phenotype
and integration into the adjacent cartilage [17–19]. The
type of biomaterial and the architecture on cellular scale
are key elements in the development of new materials
for causing targeted stem cell differentiation into specific
tissue types [20]. With a wide range of natural and syn-
thetic polymers available, selecting the appropriate bio-
material is crucial [21, 22], as the material needs to both
provide the necessary clues for cell development and dif-
ferentiation and possess excellent biocompatibility for
safe implantation. The polysaccharide chitosan, a com-
ponent of crustacean and insect exoskeletons [23–25], is
a copolymer of glucosamine and N-acetyl-glucosamine,
obtained by the deacetylation of chitin. It is the most
widely used biopolymer in various biomedical applica-
tions because of its potential to stimulate hemostasis
and accelerate the regeneration of damaged or lost tis-
sues in the process of wound healing [26, 27]. It has a
hydrophilic surface that enhances cell adhesion, prolifer-
ation and differentiation, efficiently attracting fluids and
cells to the defect site [28]. Chitosan has been shown to
mimic native matrix components in their interaction
with developing chondrocytes and possess excellent bio-
compatibility [29], biodegradability and physicochemical
properties mimicking native chondrogenic matrix, mak-
ing it suitable for cartilage tissue engineering [27, 30].
When combined with predisposed stem cells and mor-
phogens it could become a viable alternative to other
cartilage tissue engineering candidates. However, as our
previous research has shown, chitosan on its own has
only very limited articular cartilage forming capabilities
which has to a great extent limited its use clinically [31].
In the chondrogenic differentiation process of mesen-
chymal stem or stromal cells (MSCs), members of the
transforming growth factor β (TGF-β) supergene family
play a crucial role [32–34]. Building on previous results
for the interaction of TGF-β with chitosan, we aim to in-
vestigate whether combinations with other TGF-β super-
family members, specifically hBMP-6, increases articular
cartilage formation potential as compared to the effect
of TGF-β3 used alone or in combination with IGF-I.
TGF-β3 has been described in various studies to pro-
mote cartilage repair and accelerate cartilage differenti-
ation, upregulating the expression of genes typical for
the formation of cartilage in hADSCs [33, 35]. The same
genes, however, are activated in growth plate chondro-
cytes when endochondral ossification ensues. A previous
study documented that TGF-β1 and TGF-β3 have a simi-
lar effect on cell proliferation, gene expression and ar-
ticular cartilage biosynthetic activity in ADSCs cultured
in alginate beads [36]. Cals et al. [37] reported that no
significant differences in total collagen and GAG forma-
tion could be observed among MSCs cultured in
medium containing the three TGF-β isoforms, respect-
ively. Some other previous studies found that TGF-β3
was more efficient and potent than TGF-β1 in enhancing
hADSCs and MSCs chondrogenic differentiation [38].
Other studies again have also shown that TGF-β3 is very
beneficial for cartilage as it stimulates chondrocytes
in vitro by inducing the elevation of proteoglycans and
the production of collagen type II [32, 34, 39]. However,
studies in a primate model have consistently shown that
hTGF-β3 induces endochondral ossification rather than
true articular cartilage formation in vivo, with recent re-
search suggesting that the addition of human bone mor-
phogenetic protein 6 (hBMP-6) promotes formation of
hyaline, articular-like cartilage formation of both MSCs
and hADSCs [31, 40–43].
Cellular chondrogenic differentiation pathways are in-
fluenced by BMPs via specific type I and type II BMP-
receptors, activating Smads pathways [44]. BMP-6 is
mainly expressed in cartilaginous tissue, in which mes-
enchymal cell differentiation into chondrocytes is stimu-
lated, promoting the synthesis of chondrocytes and
articular cartilage-specific glycoproteins [45]. At the
same time, BMP-6 is also a known factor involved in the
induction of bone formation [46], indicating a multi-
functionality in the regulation of bone and cartilage cell
development similar to most BMPs and other growth
factors of the TGF-β superfamily. Though diverse
groups have shown that BMP-6 can stimulate chondro-
cyte and cartilage formation [47, 48], to date results re-
main unspecific as to whether hyaline articular or
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endochondral ossification type cartilage is formed, mak-
ing interpretations or validations problematic.
As various studies have assessed the biocompatibility
and tissue engineering capabilities of pure and porous
chitosan scaffolds with ADSCs, the primary aim of the
present study was determining if the in vitro cartilage
formation potential can be directed towards lasting, hya-
line articular tissue when using a chondrogenic medium
supplemented with hTGF-β3 and hBMP-6 as opposed to
the standard chondrogenic medium normally containing
only hTGF-β3. Subsequently, the study also sought to
validate our previous research [31] that the matrix for-
mation was articular and that hTGF-β3 alone causes en-
dochondral bone formation and does not support
articular chondrogenesis. Answering these questions can
not only lead to improved in vitro models for consistent
hyaline cartilage formation with biomimetic biomate-
rials, but also provide valuable information for clinical
therapeutic articular cartilage repair, possibly preventing
long-term degeneration of the treated site.
Results
Distribution and growth of hADSC in porous chitosan-GA
scaffolds
The chitosan scaffolds used in this study appeared as a
soft and highly porous sponge-like cylinders (Fig. 1a).
Pores were fairly uniform and showed irregular morph-
ology (Fig. 1b), with porosity determined as 211 ± 66 μm
from image analysis (length of cross-section measure-
ments using ImageJ, NIH). The pore size distribution of
the scaffolds used was overall evenly distributed and iso-
tropic as a result of an optimized freeze-drying process
(43). Mechanical properties could not be measured dir-
ectly, as compression forces were below the range of our
equipment, but they can be considered similar as de-
scribed in other publications, as reviewed e.g. by Leven-
good et al. 2014 [49]. Values between 0.3MPa tensile
strength and 15.7 kPa [50] are given. After lyophilization,
and especially with glutaraldehyde-crosslinking, the ma-
terial does not swell in medium and retains sufficient ri-
gidity to transfer mechanical cues to the cells.
Cells appeared well attached after 24 h (Fig. 1d-g) and
distributed throughout the scaffold. Despite static
culture, hADSC continued to grow well in the entire
construct, forming abundant matrix (Fig. 1h-k). Matrix
formation was strong with both hTGF-β3 and hTGF-
β3 + hBMP-6, with no obvious difference between both
treatments. In comparison, cells cultured without
growth-factors showed less proliferation and matrix de-
velopment (Figs. 1, 2 and 3). By day 14, abundant fibrous
matrix had already formed (Fig. 1l-o) and after 28 days,
the scaffold structure had completely disappeared under
the newly formed matrix (Fig. 1p-s). The development
and the stimulating effect of the growth-factors did not
seem impaired in the inner pores as compared to the
outer rim, as no differences were found in SEM analysis.
In order to evaluate cell viability and proliferation on
the hADSCs-seeded scaffolds, a WST-1 test in combin-
ation with a PicoGreen assay was performed 24 h after
cell seeding and subsequently after 7, 14 and 28 days of
incubation. Both cell viability and cell number, as indi-
cated by DNA amount, increased progressively over the
28 day incubation period, indicating a steady increase of
cells in all experimental groups, with a characteristic de-
crease in slope after 14 days marking the onset of differ-
entiation (Fig. 2). The course of both parameters was
alike and there was no difference between CS cultures
and those treated with additional BMP-6. From day 7,
there was a clear gap between cultures with growth-
factor medium and those with proliferation medium,
which widened in the further course (Fig. 2). When dif-
ferentiation starts, cells usually switch from multiplica-
tion to matrix production, so growth factors often
inhibit proliferation as compared to normal media. In
this case, however, both cell proliferation (Fig. 2b) and
cellular activity (Fig. 2a) were significantly higher under
the influence of differentiation medium.
Histological and immunofluorescent analyses of matrix
formation
The quality of the matrix formed was analyzed using
Alcian blue staining for cartilage GAG in both scaffold
(Fig. 3) and pellet cultures (Fig. 4). A clear enhancement
of Alcian blue positive matrix formation by the applica-
tion of growth factors was observed in the scaffolds (Fig.
3) supported by the histomorphometrical assessment
(Fig. 5). The matrix was distributed throughout the scaf-
fold with both treatments, with regional differences in
density that are commonly observed after in vitro cul-
ture without mechanical stimulation at this stage.
A different picture arose for cell pellets. Pellet culture
mimics cartilage nodule formation, giving a natural en-
vironment for chondrocyte differentiation, thus reliably
leading to some form of cartilage formation in most
cases. Accordingly, a certain amount of Alcian-positive
matrix was found after culture in normal medium (Fig.
4d). Pellets cultured with hTGF-β3 reach the same size,
but had a much higher cellular density, coalescing with a
heterogeneous histological picture (Fig. 4b), while the
combination with hBMP-6 lead to much larger pellets
with more matrix surrounding the cells (Fig. 4c).
Although the pellets were not immunostained, the
Alcian blue results (Fig. 4e, f) can be interpreted such
that with hTGF-β3 only, a very heterogeneous, partly
condensed, partly hypertrophic tissue was formed, while
the mature parts of pellets cultivated with hBMP-6 show
strong and evenly distributed positive staining for cartil-
age matrix GAG.
Huang et al. BMC Biotechnology           (2020) 20:48 Page 3 of 20
Using immunofluorescence for a more detailed ana-
lysis of the matrix formed, the deposition of aggrecan
(ACAN), an important and specific component of cartil-
age matrix, appeared to be slightly higher with hTGF-β3
treatment only (Fig. 6). No ACAN was expressed
without growth factors. The quality of tissue engineered
cartilage is strongly defined by the relation of collagen II
to collagen I formation. Collagen I does not belong to
functional hyaline cartilage, with collagen II fibers giving
the basic framework of the cartilage matrix. Here, almost
no collagen II was found when no growth factors were
applied (Fig. 7), but also no collagen I (Fig. 8). Because
proliferating chondrocytes usually form some amount of
collagen I matrix and to exclude antibody functionality,
immunohistochemical staining was performed (Suppl.
Fig. 1) to validate collagen I results. A weak signal was
detected in both normal proliferation medium and
hTGF-β3 at day 14 and 28 (Suppl. Fig. 1B, C, E, F) yet
remained absent throughout hTGF-β3 + hBMP-6 groups.
It is therefore probable that the background noise form
scaffold absorbing the immunofluorescent signal is af-
fecting the detection of the collagen I and not the
Fig. 1 Scaffold characteristics and cell distribution in culture with hADSCs at different time points. a Stereomicroscopic image of the dry scaffold,
showing sponge-like uniform porous structure. b Scanning electron microscopy images of chitosan scaffolds before and (c) after incubation with
medium (cell-free blank). Image in B was used for pore size determination. Images d-s demonstrate cellular growth on days 1 (d-g), 7 (h-k), 14 (l-
o) and 28 (p-s), the first two images showing growth with hTGF-β3 only, the second with hTGF-β3 + hBMP-6. Grey-scale images (first and third
column) are SEM images, fluorescent images (second and fourth column) are live/dead stain with green = Calcein AM for live and red = Ethidium
bromide for dead cells. Collagenous fibrous matrix (black arrows) (h-k) For (a) magnification was set at 4x; SEM magnifications were set at 100x
(b), 300x (c, d, h, j, l, p, r), 1.10Kx (f, n); Live/Dead magnifications were set at 10x (e, g, i, k, m, o, q, s)
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antibody itself. Abundant collagen II could be found
with hTGF-β3 treatment, whereas the addition of
hBMP-6 seemed to reduce the amount of this protein by
day 28 (Fig. 7). Collagen X (Suppl. Fig. 2) was not de-
tected in control and treatment groups.
The differences between chitosan-scaffold and the
pellet culture were striking. Embedded in the polysac-
charide, hADSC respond to both growth-factor
regimes with abundant matrix formation, with no dif-
ferences in distribution and amount of Alcian-blue
positive matrix and even a stronger formation of col-
lagen II under hTGF-β3 only. In pellet culture, the
hADSC remain limited in matrix formation without
additional hBMP-6, forming a heterogeneous tissue
with apparently hypertrophic regions. The immuno-
fluorescent matrix analysis has given unclear results
Fig. 2 a WST-1 (cell viability) and b PicoGreen (cell proliferation) assays for hADSCs on chitosan scaffolds cultured with normal (NS), standard
chondrogenic (CS) or modified chondrogenic + hBMP-6 (CS + hBMP-6) medium. (***p < 0.001)
Fig. 3 Alcian blue staining for GAG in chitosan scaffolds seeded with hADSCs cultured in either normal (NS) (a-c), standard chondrogenic (CS) (d-
f) or modified chondrogenic + hBMP-6 medium (CS + hBMP-6) (g-i) after 7, 14 and 28 days. Magnification 40x (Bar scales: 200 μm)
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in this case. In order to monitor more clearly the dif-
ferences gene expression was employed.
qRT-PCR of in vitro chondrogenic differentiation
To evaluate chondrogenic gene expression between the
NS, CS, CS + hBMP-6, NP, CP and CP + hBMP-6
groups, relative qRT-PCR gene analysis was performed
on in vitro samples, monitoring the relative change in
transcription of ACAN, COL1A1, COL2A1, COL10A1,
SOX9 and COMP. The results represent a snapshot of
the above genes at day 7, 14 and 28 after culturing with
standard chondrogenic, modified chondrogenic induc-
tion medium or normal medium in chitosan-based
scaffolds seeded with hADSCs or in the form of a 3D
Fig. 4 H&E and Alcian blue staining of 3D hADSCs pellets cultured in either normal (a, d), standard chondrogenic (b, e) and modified
chondrogenic + hBMP-6 medium (c, f) at day 28. H&E staining of the 3D hADSCs pellet cultures in normal medium (NP). Magnification 20x (Bar
scales: 200 μm)
Fig. 5 Histomorphometrical assessment of GAG (alcian blue) staining percentage between NS, CS and CS + hBMP-6 groups. (*p < 0.05,
**p < 0.01, ***p < 0.001)
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pellet. The results have been normalized to four refer-
ence genes (ACTB, RPLP0, TBP, POLR2e), expressed as
log10CNRQ (calibrated normalized relative quantities,
CNRQ). Relative expression of every gene in different
groups but at the same time point is shown in Suppl.
Fig. 3, whereas of every gene at different time points but
in the same group is shown in Fig. 9.
The hyaline cartilage matrix ACAN and COL2A1 ex-
pressions were found to be up-regulated in all groups
(Fig. 9a, c) and increased significantly by day 28 in both
pellets and cell-scaffold constructs treated with either
chondrogenic medium (p < 0.05) (Fig. 9a, c). ACAN was
much higher in all growth factor- (GF-) treated groups
and collagen II in both GF-treated scaffold cultures, and
both increased in expression with culture time (Fig. 9a,
c). Interestingly, for chitosan-scaffold cultures, both
genes showed a greater increase in expression under ei-
ther GF-treatment, decreasing in normal medium, whilst
in pellet culture, ACAN slightly increased and COL2A1
remained constant over time in normal medium, with
no significant increase of the latter under hTGF-β3 treat-
ment. With additional hBMP-6, pellets expressed slightly
more COL2A1 on day 14, but significantly less on day
28.
The cartilage-oligomeric matrix protein (COMP) is an
important regulator of matrix formation; the nuclear
transcription factor SOX9 is considered the central
orchestrating signaling molecule of cartilage differenti-
ation. Both clearly responded to growth-factor treat-
ment, more clearly so for scaffold cultures. COMP and
SOX9 were both upregulated in CS group at all-time
points and the expression increased significantly by day
14, greatly exceeding values for pellets, but decreased
slightly at day 28 (Fig. 9e, f), whereas in the CS + hBMP-
6 groups, COMP was upregulated briefly at day 7 after
which it significantly decreased by day 28 (Fig. 9e, f).
Both genes were more strongly expressed with time in
pellet cultures, COMP remaining downregulated in pro-
liferative and becoming slightly upregulated in hTGF-β3
medium, yet further downregulated with hBMP-6 (Fig.
9e, f). SOX9 expression in pellets with normal medium
was downregulated at day 7 and 14, but upregulated at
day 28, whereas being downregulated at all-time points
in normal medium with scaffolds group (Fig. 9e, f). As in
Fig. 6 Immunofluorescence staining of aggrecan (green) at day 7, 14 and 28 in chitosan scaffolds with hADSCs cultured in normal (NS), standard
chondrogenic (CS) or modified chondrogenic + hBMP-6 medium (CS + hBMP-6). The chitosan scaffolds fluoresced yellow, whereas living cell
nuclei fluoresced blue. Magnification set a 10x
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scaffolds, COMP expression in pellets was significantly
higher in chondrogenic groups at all-time points, while
contrary to the former, SOX9 was not consistently so,
expression levels being more or less equal for all treat-
ments in pellets on day 28 (Suppl. Fig. 3E, F).
When analyzing cartilage matrix formation, it is insuf-
ficient to look at existing expression of positive markers,
as these are common also in matrix destined for
hypertrophy and mineralization. Here, COL1A1 and
COL10A1 were included as negative markers for
differentiation towards articular cartilage, as they are in-
dicators for endochondral bone formation [54, 55]. The
qRT-PCR results for those genes showed some similar-
ities with the optical impression of histological images
(Suppl. Figs. 1, 2).
For the fibrous tissue component COL1A1 was gener-
ally downregulated, yet slowly increasing in pellet cul-
tures, higher in scaffolds with normal medium but
clearly upregulated in scaffolds and pellets with hTGF-
β3 treatment (Suppl. Fig. 3B). Similar to dedifferentiation
processes in 2D culture, it increased with time in all
treatments except for scaffolds supplemented with
hTGF-β3 + hBMP-6, where it was clearly and progres-
sively downregulated (Fig. 9b). In pellet culture, down-
regulation of COL1A1 was even stronger with hBMP-6,
reaching the lowest level of all samples.
COL10A1 expression was downregulated in both pellet
cultures and scaffolds cultures with normal medium
(Suppl. Fig. 3D), but intriguingly decreasing in expres-
sion in NP only, increasing towards day 28 in the other
two (Fig. 9d). Similar to collagen I, this clear signal of
beginning hypertrophy was increased in pellets by
hTGF-β3 treatment in hADSC. Most striking in the ex-
pression pattern of COL10A1 however is the difference
between pure hTGF-β3 treatment and the addition of
hBMP-6 in scaffold cultures. The expression level rose
to the point of upregulation with hTGF-β3, but remained
low with additional hBMP-6. There was no such con-
trasting influence on chondrocytes in pellet culture.
In interaction with the chitosan matrix, hTGF-β3 had
a stronger effect on chondrogenic gene expression in
hADSC, but also induced hypertrophy, part of which
was rescued by adding hBMP-6. Although histological
analysis revealed stronger differences between growth
Fig. 7 Immunofluorescence staining of collagen type II (green) at day 7, 14 and 28 in chitosan scaffolds with hADSCs cultured in normal (NS),
standard chondrogenic (CS) or modified chondrogenic + hBMP-6 medium (CS + hBMP-6) . The chitosan scaffolds fluoresced yellow, whereas
living cell nuclei fluoresced blue. Magnification set a 10x
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factors samples with and without additional hBMP-6 for
pellets and not for scaffolds, qRT-PCR showed an effect
of hTGF-β3 on the expression of COL10A1 in scaffolds
that was not found in pellet cultures. Moreover, the in-
fluence of hTGF-β3 medium on the expression of
COL2A1, COL1A1, COMP and SOX9 was much stronger
in scaffolds, while the “rescuing” effect of additional
hBMP-6 was much weaker for COL1A1 and COMP.
Discussion
Articular cartilage regeneration remains a challenging
clinical task [2, 4, 51], despite several promising
approaches using adapted scaffold materials and a com-
bination of stem cells with growth factors [52–56]. Bio-
materials used in cartilage tissue engineering need to be
highly biocompatible, biodegradable, as well as posses-
sing the adequate biomechanical properties and geomet-
ric organization that further support cell attachment,
proliferation and differentiation [17–19]. As such, the
ideal scaffold should mimic the extracellular cartilage
matrix, in both form and function, and retain the
phenotype of differentiated stem cells [57]. One such
material is chitosan, a polysaccharide derived from the
exoskeleton of arthropods, which has shown to be one
of the more advantageous substances that has been
widely investigated and used in various derivative forms
in tissue engineering as well as for clinical applications
[58]. In particular, scaffolds composed of poly(lactic-co-
glycolic acid) (PLGA)/chitosan have been shown to sup-
port chondrocyte development from hADSCs and to
form articular cartilage in a lagomorph model over 12
weeks [20, 59, 60]. Compared to chondrocytes isolated
from mature cartilage and BM-MSCs isolated from bone
marrow, hADSCs can be harvested in large amounts and
are readily accessible [61]. Human ADSCs can be ex-
panded in stable cultures of undifferentiated cells and
can easily be differentiated into chondrocyte-like cells
in vitro under specific culture conditions, maintaining
the chondrogenic phenotype even in vivo after trans-
plantation [62, 63]. However, as shown in our previous
study [31], the use of hADSCs cultured on a pure, elastic
and porous scaffold composed of glutaraldehyde-cross-
Fig. 8 Immunofluorescence staining of collagen type I (green) at day 7, 14 and 28 in chitosan scaffolds with hADSCs cultured in normal (NS),
standard chondrogenic (CS) or modified chondrogenic + hBMP-6 medium (CS + hBMP-6). The chitosan scaffolds fluoresced yellow, whereas living
cell nuclei fluoresced blue. Magnification set a 10x
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linked chitosan is inadequate for articular cartilage re-
generation. Without the correct soluble signals, the bio-
mimetic matrices can only assist new tissue formation
relying on additional morphogens to facilitate faster tis-
sue growth in the regeneration for large defects. Yet, the
correct signaling proteins needed to for the formation of
stable hyaline cartilage (reviewed in [64]) within
biomaterials have not been properly identified. Cartilage
regeneration approaches using stem cells generate chon-
drocytes that, whilst depositing a chondrogenic-like
matrix, have a strong tendency to either deposit large
amounts of collagen I in a fibrous tissue or, even more
often, go into hypertrophy in a mineralizing matrix that
initiates endochondral ossification [65]. When following
Fig. 9 Relative gene expression quantity of (a) ACAN, (b) COL1A1, (c) COL2A1, (d) COL10A1, (e) COMP and (f) SOX9 between all culture groups
(N = normal medium; C = chondrogenic medium, P = 3D Pellet; S = chitosan scaffolds,). (*p < 0.05, **p < 0.01, ***p < 0.001). The baseline 0
represents untreated hADSCs in monolayer, which was the normalisation factor
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up on attempts to illuminate underlying mechanisms
and improve the clinical situation, methodological in-
consistencies appear, producing non-standardized and
non-reproducible results. Indeed, some morphogens
such as the hTGF-β3, accepted as a common chondro-
genic stem cell differentiation morphogen [66], have
been shown to have undergone evolutionary and func-
tional variation, especially in regard to induction of bone
formation between different animal models [67, 68]. It is
therefore not clear if hTGF-β3 can truly form “articular
cartilage” on biomaterial carriers or if a synergy with at
least one more morphogen, such as used in previous
studies with hBMP-6, is required [31, 43] to achieve this.
This question was therefore assessed in the present
study in which we sought to validate our previous results
that hADSCs cultured in chitosan only form hyaline
matrix in the presence of hTGF-β3 + hBMP-6, proving
that a proper morphogen combination in the right
carrier matrix is necessary to form the correct tissue
type. It was further the intention to show that hTGF-β3
alone does not support hyaline articular formation but
leads to hypertrophy that finally ends in bone formation,
as suggested in studies by Ripamonti et al. [40–42] and
Klar et al. [69].
The in vitro viability, proliferation and differentiation
capacity of hADSCs cultivated in lyophilized scaffolds of
glutaraldehyde-cross-linked chitosan, as previously ob-
served, increased stably with culture time over the 28
days. The scaffolds with their porous structure enabled
viability, migration and proliferation of hADSCs. Results
from the Live/Dead assay demonstrated that the
hADSCs exhibited very good adhesion and biocompati-
bility on the biomaterial. Comparing the results from
this assay from 14 days onward between chondrogenic
and control groups, a strongly enhanced cell prolifera-
tion in chitosan scaffolds with chondrogenic differen-
tiation medium demonstrated a positive interaction of
the carrier with the morphogens. Scanning electron
microscopy clearly showed cells colonizing the scaf-
folds, forming a lush fibrous matrix with denser layers
occurring on the periphery of the devise by 28 days.
This effect has to be attributed to the influence of
hTGF-β3, which has been shown to stimulate chon-
drocyte proliferation e.g. in rabbit articular chondro-
cytes [70], a mechanism has recently been proposed
for rat chondrocytes [71]. This could be one aspect
why TGF-β alone is not suited to induce cartilage
formation. BMP-6, on the contrary, has been demon-
strated to reduce proliferation by induction of differ-
entiation [72], a process opposed to cell growth in
articular cartilage. The overall increased growth may
be indicative of a still to large influence of TGF- β,
the balance between the two factors still has to be
adjusted for successful hyaline cartilage formation.
A strong indication for the chitosan’s capacity to sup-
port the induction of chondrogenesis by growth factors
was the detection of both glycosaminoglycan (GAG) syn-
thesis, a part of the extracellular matrix of cartilage, as
well as collagen type II transcription and translation to-
gether with ACAN and SOX9 upregulation. Human
ADSCs cultured on chitosan scaffolds with normal
medium did not show substantial formation of GAGs
compared to both those cultured in standard or modi-
fied chondrogenic medium and the corresponding 3D
pellet controls. This was in accordance with results of
immunofluorescent, immunohistochemical, histomor-
phometrical analysis and qRT-PCR assays. COL2A1 was
significantly down-regulated by day 28 in the NS group
with ACAN and SOX9 also decreasing substantially com-
pared to the same normal medium group with 3D-
pelleted hADSCs. The relative gene expression assay of
chondrogenic differentiation markers further supported
this finding where ACAN and SOX9 expression in-
creased in both chitosan groups irrelevant of medium
type, even though COL2A1 was only significantly upreg-
ulated in chondrogenic medium. The transcription fac-
tor SOX9 is an early marker for chondrogenesis that
regulates collagen type II and cartilage-specific matrix
synthesis by activating the COL2A1 and ACAN [73, 74].
Another study previously demonstrated that SOX9 was
also expressed in proliferating and pre-hypertrophic
chondrocytes, but is downregulated in hypertrophic
chondrocytes [75]. From the present results, it appears
that the chitosan scaffold on its own can induce hADSCs
to undergo differentiation towards a cartilage lineage but
cannot form a cartilage matrix without the addition of a
subsequent stimulant, which was the case for the CS,
CS + hBMP-6 and CP groups where hTGF-β3 alone or
in combination with hBMP-6 was used. Indeed, through
the addition of hBMP-6, SOX9 significantly increased
and was greater than the standard CS group, a pattern
that remained consistent for all gene types including
ACAN and COL2A1.
Immunofluorescence staining of collagen type II and
aggrecan as well as histological staining with Alcian blue
for GAG confirmed that the groups treated with hTGF-
β3, CP and CS and hTGF-β3 + hBMP-6 showed an in-
crease both on the translational and transcriptional
levels of most cartilage relevant markers. In particular in
the chitosan group, histological and immunofluores-
cence staining demonstrated that GAG and collagen
type II synthesis was significantly increased during the
in vitro culture over 28 days, indicating that indeed this
biomaterial supports the formation of specific matrices
in this case those consisting of collagen type II as is the
case for cartilage. ACAN, COL2A1 and SOX9 expression
levels all increased significantly, suggesting that the
chitosan scaffold alone provides a far superior
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microenvironment that allows for the adhesion, prolifer-
ation and differentiation of cells under the influence of
both chondrogenic medium types, especially with a com-
bination of hBMP-6 and hTGF-β3.
However, one crucial question in cartilage regener-
ation in vitro is whether the matrix formed is hyaline or
contains significant amounts of collagen I, and if it is
hyaline matrix does it develop towards stable articular
cartilage or rather progresses towards hypertrophy and
mineralization. ACAN, COL2A1 and SOX9 are markers
that are generally utilized to monitor if any cartilage for-
mation had occurred irrelevant of the type [76–78].
COL1A1, COL10A1 and COMP on the other hand are
classical markers to further differentiate what type of
cartilage is being formed [77, 79, 80]. Articular cartilage
has superior load-bearing and mechanical properties and
is free of collagen I [81, 82], while hyaline cartilage
formed during endochondral ossification of embryogen-
esis for certain skeletal bones, is characterized by the
early appearance of collagen X [83]. In our study, colla-
gen type I immunofluorescence/histochemical staining
was minimally detected in NS and CS but not CS +
hBMP-6 at day 7, 14 and 28, strengthening our previous
articular hyaline cartilage formation discoveries [31].
This corroborated with the gene expression patterns for
COL1A1 suggesting that cultures were not purely articu-
lar and already programmed towards hypertrophy, ex-
cept for the chitosan scaffolds cultured in the modified
hTGF-β3 + hBMP-6, where these genes were all signifi-
cantly and consistently down-regulated (Fig. 9b, d).
Whilst COL10A1 was downregulated with immunohisto-
chemical staining validating gene expression results,
COL1A1 decreased significantly in the standard chon-
drogenic chitosan or whilst in the pellet culture.
COL1A1 remained high and only after day 28 had min-
imally decreased, but not significantly, as is expected
during articular cartilage formation. Whilst stem cells, in
the absence of a carrier matrix, could have a higher
probability to become articular chondrocytes in the pres-
ence of hTGF-β3, the latter’s cartilage formation poten-
tial is far too low to be considered on its own for large
scale in vivo cartilage repair. It appeared that the chito-
san scaffolds creates a superior environment to support
large scale cartilage matrix production, provided that the
correct morphogens are present to facilitate the correct
matrix formation [13, 14]. This was made evident by the
expression of COMP, a pentameric non-collagenous
matrix protein expressed primarily in articular cartilage.
It is reported to regulate both chondrogenesis and endo-
chondral ossification, including stabilizing the ECM of
articular cartilage, by maintaining the structural integrity
through its interaction with ACAN, COL2A1, COL10A1
and fibronectin [84–86]. Results shown here in part re-
capitulate our previous observations [31], with COMP
being downregulated as compared to unstimulated
hADSCs in the monolayer in all groups except for the
CS and CS + hBMP-6 groups cultured for 7 (CS +
hBMP-6 and CS) and 14 (CS only) days. During the first
7 days, COMP expression was not different between CS
and CS + hBMP-6. Only by Day 14, COMP in the CS +
hBMP-6 was downregulated here with the CS group
only following this trend by day 28. This suggests that
TGF-β3 on its own enhances the production of an extra-
cellular matrix that is however not articular in nature as
evidence by the expression of COL1A1 and COL10A1.
At Day 28, COMP group decreased in its expression pat-
tern in both CS and CS + hBMP-6 groups, similar to
observations reported before [87]. We suggest that the
balance between the TGF- β3 and BMP-6 was not ad-
justed well enough to avoid the decrease in the medium
containing both growth-factors. COMP is a matrix elem-
ent with several important functions, among which there
is an important role in adipose tissue [88], the source of
the stem cells used. Possibly, depending on the donor,
cells had maintained a high COMP expression and the
observed downregulation was indeed a regulation to
normal levels.
Indeed, the results further demonstrated clearly that
hTGF-β3 alone is not a suitable morphogen for articular
cartilage formation as has been suggested before but ig-
nored for most part in the tissue engineering field [89–
91]. Our results unequivocally demonstrated that hTGF-
β3 alone causes endochondral cartilage formation
tending towards ossification rather than true articular
cartilage development, unless it is counteracted or syner-
gizes with another TGF-β supergene family member(s)
that modulate better the process of articular cartilage
formation, here hBMP-6. Although the current literature
does not explicitly state this, as it generalizes more
on the term chondrogenesis [47, 48], we can now
with a better degree of certainty claim that the synergetic
effect of hBMP-6 with hTGF-β3 causes “articular”
chondrogenesis.
The TGF-β isoforms have previously been established
to supposedly possess good “chondrogenic differenti-
ation potentials” when utilizing MSCs [66] as much of
the TGF-β isoforms are present in articular cartilage
with even miniscule quantities of active TGF-β being a
potent stimulant for proteoglycan and type II collagen
synthesis. This was again substantiated in the present
study where 10 ng/ml of hTGF-β3 promoted significant
chondrocyte differentiation and resulted in increased
type 2 collagen transcription and translation [16] but in
hADSCs. Indeed, most of the previous studies on the ar-
ticular cartilage differentiation potential were based on
MSCs, and were solely focused on whether TGF-β iso-
forms also possess similar chondrogenic differentiation
capacitates as ADSCs [92]. Whilst in vitro traits of TGF-
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β isoforms at inducing articular chondrogenesis show in-
creased COL2A1, SOX9, ACAN and reduced COL1A1
expressions [93, 94], in vivo based research remains
problematic; despite extensive investigations demon-
strating the potential of MSCs to regenerate cartilage,
the latter degenerates quickly in vivo after a certain
number of weeks, leading to ossification rather than
maintaining articular cartilage state [60, 94]. The ques-
tion must therefore be asked whether the matrix was ar-
ticular to begin with. Indeed, in the present study similar
gene expression results with respect to COL2A1, SOX9
and ACAN were produced in hADSCs too, supporting
the concept that TGF-β isoforms, especially hTGF-β3,
can induce a form of chondrogenic differentiation also
in these stem cells [92]. However, the exception of
COL1A1 at day 28 in both pelleted hADSCs in the ab-
sence of standard chondrogenic medium (Fig. 9b) and
the enhanced expression of COL1A1 and COL10A1 in
the biomimetic chitosan scaffolds, replicating in part an
in vivo environment, would suggest that previous theor-
ies are not quite as accurate, possibly due to outdated
qPCR techniques [65, 69], or that not all stem cells share
equal cellular differentiation capabilities to undergo
transformation into certain cell types for the formation
of specialized tissue matrices. Even in studies using cer-
tain BMP members such as BMP-7, BMP-2 and BMP-4
alone as part of chondrogenic medium instead of a
TGF-β isoform, promising in vitro results were achieved
[95–98], but for in vivo applications the newly formed
cartilage structures revert to the typical ossification of
endochondral bone formation [99]. This suggests that
single morphogen applications are not sufficient at
achieving the correct cellular response to yield correct
tissue formation especially where articular cartilage for-
mation is concerned. Only by combining two morpho-
gens of the TGF-β supergene family members, here
hTGF-β3 with hBMP-6, can proper articular cartilage
formation be re-established to produce stable hyaline
cartilage, as shown in the present study and previously
postulated by [43] and us [31, 69, 100].
It therefore appears that, despite the results proving
that chitosan is a suitable carrier with a potential to sup-
port articular cartilage formation, the appropriate mor-
phogens are the key driving force for the induction of
correct matrix formation. In this model, even in the
presence of a suitable carrier matrix, the correct “keys”
are needed to open the locking mechanism of correct
tissue morphogenesis. Our findings confirm that hTGF-
β3 alone is not suited as an articular cartilage-inducing
morphogen for hADSCs. Previous concepts may need to
be re-evaluated in light of modern molecular techniques
based on advanced qRT-PCR techniques as stated by
Bustin et al. [101] or Next Generation Sequencing that
will provide detailed molecular mechanistic insights into
the underlying mechanisms of single TGF-β supergene
family members and multiple combined morphogen
members. Such efforts will help properly identify how
these factors act on causing stem cell differentiation to-
wards articular chondrocytes. Future research on the
regulation of these proteins and the identification of in-
trinsic cellular pathways leading to proper articular car-
tilage formation are therefore critical to avoid errors or
misinterpretations that lead to further delays in clinical
applications. Future articular cartilage regeneration pro-
cedures should consider including hTGF-β3 + hBMP-6,
and find ways to maintain the presence of these mor-
phogens for at least 28 days or more. This, if achieved,
would very likely lead to articular cartilage matrix for-
mation that does not degenerate in the future to fibro-
cartilage or osteogenic tissue.
Conclusion
Chitosan remains a viable and highly beneficial biomate-
rial that has the capacity to support extensive differenti-
ation of stem cells into chondrocytes, but may tend
towards ossification unless the correct signals are
present. Human ADSCs have been shown to be a com-
petitive alternative stem cell type that has many excel-
lent qualities to differentiate into the appropriate cell
types including chondrocytes, provided that the correct
signaling molecules are present. Human TGF-β3, how-
ever, does not properly facilitate articular cartilage chon-
drocyte differentiation in hADSCs in pellet or on a
biomaterial, rather tending towards inducing endochon-
dral cartilage formation that will in the long run ossify.
Moreover, our results confirmed that only by using an
optimized morphogen mixture together with a suited
carrier matrix may provide a more efficient environment
at regenerating articular cartilage defects than existing
strategies, as hBMP-6 with hTGF-β3 maintains an articu-
lar cartilage formation milieu.
Methods
Biomaterial scaffold design
Porous sponges were manufactured by lyophilization of
glutaraldehyde-cross-linked 0,5% wt/vol chitosan hydro-
gels as described previously [31]. Briefly, chitosan with a
95% degree of deacetylation (Heppe Medical, Halle,
Germany) was dissolved at 1% wt/vol in 0.1 N HCl with
pH 1. Using 1 N NaOH, the pH was carefully adjusted to
5 under constant stirring and dropwise addition of the
base. Hydrogels were formed by mixing 1 ml of chitosan
solution with 1 ml aqueous 1% glutaraldehyde solution
(Sigma-Aldrich, St. Louis, MI, USA) in hollow disc
shapes with a diameter of 15 mm. After gelation, sam-
ples were frozen at − 32 °C using polystyrene insulation
to control freezing rate. Frozen samples were then
freeze-dried at − 50 °C under vacuum using an Alpha 1–
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4 LD system (Christ, Osterode am Harz, Germany). The
dry scaffolds were then trimmed on both ends to a final
height of 8 mm with a microtomic blade and gamma-
sterilized at ca. 27 kGy.
The resulting scaffold morphologies were examined
using a VHX-5000 3D digital microscope (Keyence,
Osaka, Japan) and software VHX-5000 Ver. 1.6.1.0 /
System Ver. 1.04 (Keyence). The microstructure of the
scaffolds was observed by scanning electron microscopy
(SEM) (JEOL JSM-6360LV, Tokyo, Japan).
Isolation and culture of hADSCs
Human ADSCs were isolated, as previously described
[31, 102], from subcutaneous adipose tissue from 4 pa-
tients of different sex and age (age 31–80, BMI 29–52)
that was acquired from the Biobank of the University
Hospital of Munich Germany which operates in accord-
ance to the European Union compliant ethical and legal
framework of the Human Tissue and Cell Research
Foundation (http://www.htcr.org). The research was ap-
proved by the Human Ethics Committee of the Faculty
of Medicine at the University of Munich and the
Bavarian State Medical Association. Briefly, harvested
adipose tissue were rinsed with phosphate buffered sa-
line (PBS) containing 180 IU/ml penicillin/streptomycin
and 0.75 μg/ml amphotericin B (Biochrom, Berlin,
Germany), after which the tissue was cut into small frag-
ments and digested with 0.2% collagenase A solution
(Sigma-Aldrich) in DMEM (Gibco, Waltham, MA, USA)
at 37 °C. Then 15% fetal calf serum (FCS; Sigma-
Aldrich) supplemented culture medium was added, after
which the mixture was resuspended, filtered through
100 μm sieves and centrifuged at 400 g for 10 min at
room temperature (RT). The pellet containing hADSCs
was resuspended with fresh growth medium (DMEM,
15% FCS, 60 IU/ml penicillin/streptomycin), seeded in a
T-75 culture flask and cultured at 37 °C with 5% CO2 for
24 h. Subsequently, the adhered cells were washed with
PBS and 20ml of fresh growth medium was added. The
medium was replaced every 3 days. Human ADSCs used
in this study were used at passage 4.
Cell seeding onto chitosan sponges and in vitro
chondrogenic differentiation
The dry scaffolds were placed carefully in a 12-well plate
(Thermo fisher scientific, Waltham, MA, USA) and cov-
ered with 2 ml normal growth medium (high-glucose
DMEM 4.5 g/L D-glucose, 110 μg/ml Pyruvate; Gibco,
supplemented with 10% FCS, 60 IU/ml penicillin/
streptomycin). Scaffolds were then incubated at 37 °C
with 5% CO2 for 6 h after which the medium was chan-
ged and left to incubate overnight. Human ADSCs (~
90% confluent) were digested with trypsin/EDTA and
counted and resuspended at a concentration of ~ 1 ×
107/ml. To seed the cells on the chitosan scaffolds, the
old medium was removed and 100 μl of cell suspension
was pipetted evenly onto each. Scaffolds with cells were
incubated at 37 °C at 5% CO2 for 1 h to allow for cell at-
tachment, whereupon 2ml of normal growth medium
was added to each well and incubated overnight. The
following morning (Day1), the cell-seeded scaffolds were
transferred into either normal growth medium (Normal
+ Scaffold or “NS”; n = 9), standard chondrogenic
(hTGF-β3) medium (Chondrogenic + Scaffold or “CS”;
n = 9) or modified chondrogenic (hTGF-β3 + hBMP-6)
medium (Chondrogenic + hBMP-6 + Scaffold or “CS +
hBMP-6”; n = 9). The standard chondrogenic medium
was normal growth medium supplemented with 10 ng/
ml recombinant human TGF-β3 (R&D Systems,
Minneapolis, MN, USA), 100 nM dexamethasone
(Sigma-Aldrich), 50μg/ml L-ascorbic acid-2-phosphate
(Sigma-Aldrich), 40μg/ml L-proline (Sigma-Aldrich) and
ITS+ 1 (Sigma-Aldrich; final concentrations: 10 mg/L in-
sulin, 5.5 mg/L transferrin, 4.7 μg/ml linoleic acid, 0.5
mg/ml bovine serum albumin and 5 μg/L selenium).
Chondrogenic + hBMP-6 medium was the standard
chondrogenic medium as described above + 10 ng/ml re-
combinant hBMP-6 [22]. The cell-seeded constructs cul-
tured with normal growth medium (NS) were
considered as scaffold control group. Samples were cul-
tured for 7, 14, and 28 days and medium was replaced
every 3 days.
Pellet culture and chondrogenic differentiation
Pellet culture was used as comparable, scaffold-free 3D
culture control [103], to investigate both scaffold and
culture medium influence on stem cell differentiation
and matrix formation. Human ADSCs from the fourth
passage were resuspended at a concentration of 2.5 × 105
cells per ml in normal growth medium (see above). Two
milliliters of the cell suspension containing 5 × 105
hADSCs were transferred into a 15mL polypropylene
conical tube and centrifuged at 500 x g for 5 min to
allow for 3D cell pellet formation. The 3D pelleted cells
were then incubated overnight at 37 °C with 5% CO2
with loosened caps to permit gas exchange. Spheroid ag-
gregates formed at the bottom of each tube. Next day
(Day1), the culture medium was replaced with 2 ml of
fresh growth medium (Normal + Pellet or “NP”; n = 9),
standard chondrogenic (hTGF-β3) medium (Chondro-
genic + Pellet or “CP”; n = 9) or modified chondrogenic
(hTGF-β3 + hBMP-6) medium (Chondrogenic + hBMP-
6 + Scaffold or “CS + hBMP-6”; n = 9) carefully so as not
to resuspend the cell pellet. The 3D pellet medium was
changed every 3 days, and 3D cell pellets were cultured
for 7, 14, and 28 days prior to harvest and processing for
analysis. Cells cultured in normal growth medium were
used as the pellet control group.
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Scanning electron microscopy (SEM)
Scanning electron microscopy was performed as previ-
ously described [31]. In order to see the matrix develop-
ment progression of hADSCs on the scaffolds treated
with modified chondrogenic medium, a scaffold was ran-
domly chosen and cultured for 1, 7, 14 and 28 days.
Upon harvest, the cell-scaffold constructs were washed
with PBS and fixed in 2.5% glutaraldehyde in PBS over-
night at 4 °C. The constructs were then stained with 1%
osmium tetroxide, dehydrated in a graded series of alco-
hols, dehydrated using the critical point drying method,
and coated with gold. The samples were examined with
a scanning electron microscope (SEM) at an accelerating
voltage of 20 kV (Carl Zeiss EVO LS 10, Oberkochen,
Germany).
Cell viability and proliferation assay
The viability and proliferation of hADSCs cultured in
the CHI and CHI/HA scaffolds were evaluated by means
of a water-soluble tetrazolium-1(WST-1) reagent
(Roche, Basel, Swiss) in combination with Quant-iTTM
PicoGreen dsDNA Kit (Invitrogen, California, USA) at
day 1 and subsequently at day 7, 14, or 28, as described
previously [31]. Briefly, the CHI and CHI/HA scaffolds
with the hADSCs were transferred to a new 24-well
plate and washed twice with PBS after which 0.5 ml fresh
normal growth medium containing WST-1 at 10:1 (v/v)
was added to each well and incubated for 3 h at 37 °C at
5% CO2. The absorbance of the WST-1/medium mix-
ture was read at 450 nm using a Synergy HT microplate
reader and Gen 5 2.03 software (BioTek, Vermont, USA)
in a 96-well plate. The same scaffolds were used for the
PicoGreen dsDNA Assay. Here The 1% PSCs were
washed twice with PBS. According to the manufacturer’s
protocol, the cells were lysed from the scaffold and DNA
standards were mixed with TE-buffer and subsequently
with Quant-iT PicoGreen dsDNA reagent. The samples
were excited at 480 nm and the fluorescence emission
intensity was measured at 520 nm using a Synergy HT
microplate reader and Gen 5 2.03 software (BioTek).
Cell survival in the scaffold
The effects of chitosan scaffolds on cell survival in both
normal and altered chondrogenic differentiation medium
including normal growth medium were studied by using a
Live/Dead assay, as described previously [31]. At day 1, 7,
14 and 28, the cell-scaffold constructs were stained with a
LIVE/DEAD Viability/Cytotoxicity Kit (Invitrogen,).
Briefly, cell-scaffold constructs were rinsed with PBS and
incubated in staining solution containing Calcein AM and
Ethidium homodimer-1(EthD-1) at room temperature for
30min, followed by washing with PBS. Then the con-
structs were examined by fluorescence microscopy (Carl
Zeiss). Healthy cells fluoresce green, while the nucleus of
dead cells fluoresced red [89].
Histological, immune-fluorescence and -histochemical
analysis
As described previously [31], after 7, 14 and 28 days of
culture the cell-scaffolds and 28 day 3D cell pellets were
fixed in 4% paraformaldehyde for 30 min at room
temperature. The 1% chitosan scaffolds with cells were
dehydrated through a graded series of alcohols into par-
affin, whereas the 3D cell pellet cultures were embedded
in a Tissue-Tek O.C.T.™ compound (Sakura Finetek
Germany, Staufen, Germany) and frozen in liquid nitro-
gen. Following this, 10 μm thick sections were cut using
either a Microtome (Leica, Wetzlar, Germany), for paraf-
fin specimens, or a CM 3050 cryomicrotome (Leica), for
the cryogenic embedded specimens. To visualize tissue
morphology and cartilage matrix formation, sections
were stained with Alcian blue at pH 2.5 for glycosamino-
glycan (GAG) content formation. All stained sections
were analyzed with a PreciPoint M8 Digital Microscope
& Scanner (PreciPoint GmbH, Freising, Germany).
To determine the quality of the matrix composition,
chitosan scaffold cultures within the NS, CS and CS +
hBMP-6 groups were immunofluorescenctly stained for
collagen I, collagen II, aggrecan and immunohistochemi-
cally for collagen I and collagen X (for validation pur-
poses). Briefly, paraffin sections were incubated with
primary antibodies (all from Abcam, Cambridge, UK) for
either collagen type I (1:300; Cat# ab34710), collagen
type II (1:200; Cat# ab34712), aggrecan (1:300; Cat#
ab3778) and collagen type X (1: 200; Cat# ab58632) at
4 °C overnight. The antibodies were diluted with anti-
body dilution buffer (DCS, Germany). For negative con-
trols, the first antibody was omitted. The slides were
then incubated with the conjugated secondary antibody
(Abcam, Cambridge, UK) for 1 h at room temperature.
For immunofluorescence nuclei of cells were then
stained for 8 min with Hoechst 33342 (Life Technolo-
gies, Carlsbad, USA). The slides for immunofluorsence
were mounted with Fluoromount W (Serva Electrophor-
esis, Heidelberg, Germany) air-dried and stored in dark-
ness at 4 °C, whereas those for immunohistochemical
assessment where mounted with chromogen AEC (DCS,
Germany). Fluorescence microscopy was then performed
with a Zeiss Axioskop 40 equipped with appropriate fil-
ter sets and AxioCam MRc 5 (Carl Zeiss, Munich,
Germany). Images were obtained with Axio Vision, Rel.
4.9 (Carl Zeiss, Munich, Germany). Exposure time was
kept constant for the samples where fluorescence
intensity was to be compared. On the other hand, im-
munohistochemical stained sections where captured
using PreciPoint M8 Digital Microscope & Scanner
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(PreciPoint) with AEC stained tissue staining as a wine-
reddish color.
Histomorphometrical assessment Alcian blue GAG
content
Histological cuts were processed for Alcian blue positive
matrix formation using a combination of image process-
ing codes based on ImageJ (https://imagej.nih.gov/ij/).
The pictures were first treated for noise using a
Gaussian filter (kernel = 2.0, sigma = 0.5), and then seg-
mented with a color threshold in the Red-Green-Blue
color space, selected visually to isolate pixels stained
with Alcian blue within the histological pictures and set-
ting them to 1, while other region were set to 0.. Image
parts not within the specimen region were removed. The
final %GAG content was calculated as the ratio of pixels
within the Alcian blue positive region to the total
amount of pixels within the image, after subtraction of
the external region. A mean and standard deviation was
calculated for each group at each time point, and a Stu-
dent’s T-Test was performed for statistical differences
between groups and at each time point (significance if
p < 0.05).
Quantitative real-time PCR (qRT-PCR)
As described previously [31], quantitative RT-PCR, ac-
cording to the MIQE guidelines [101], was performed to
determine the relative expression of the chondrogenic
genes, aggrecan (ACAN), collagen type II (COL2A1), car-
tilage oligomeric matrix protein (COMP), SRY-box 9
(SOX9) with collagen type I (COL1A1) and collagen type
X (COL10A1) being incorporated to determine if cartil-
age matrix development was pure articular or progres-
sing towards an endochondral ossification lineage. After
7, 14 and 28 days, total RNA was isolated using a modi-
fied RNA Trizol extraction procedure [104]. Briefly, 1 ml
Trizol (Invitrogen) was added to cell material after
which chloroform (Sigma-Aldrich) was added to permit
separation of the RNA from the proteinaceous material.
After centrifugation the aqueous RNA containing phase
was transferred to a fresh tube where the RNA was then
precipitated out by adding Isopropanol (Sigma-Aldrich).
After incubation at RT for 10 min samples were centri-
fuged at 16000 rpm over night at 4 °C, upon which RNA
pellets were then washed with 75% Ethanol (Merck,
Billerica MA, USA) and permitted to dry briefly to pre-
vent alcohol contamination. After drying, total RNA was
resuspended in 32 μl RNase free water (Gibco) after
which the concentration and purity of the RNA was de-
termined using a NanoDropTMLite spectrophotometer
(Thermo Scientific) and quality assessed with a Bioanaly-
zer 2100 (Agilent Technologies). After RNA extraction
approximately 1 μg of RNA was reverse transcribed into
complementary DNA (cDNA) utilizing the QuantiTect
Reverse Transcription cDNA Synthesis Kit (Qiagen,
Germany).
Quantitative RT-PCR was then performed in duplicate,
using the FastStart Essential DNA Green Master (Roche)
on a Light Cycler 96 thermocycler (Roche). Each reac-
tion mixture contained: 10 ng cDNA, 10 μM of each pri-
mer (Table 1), 2x FastStart Essential DNA Green Master
and RNase-free water to a final reaction volume of 20 μl.
The primers of six target genes were designed using
Gene fisher v. 2.0 (http://bibiserv.techfak.uni-bielefeld.
de/genefisher2) and optimized according to the MIQE
Guidelines [101]. Use of GeNorm (http://medgen.ugent.
be/~jvdesomp/genorm/) established that TATA sequence
binding protein (TBP), succinate dehydrogenase complex
flavoprotein subunit A (SDHA), ribosomal protein lateral
stalk subunit P0 (RPLP0) and Ribosomal Protein L13a
(RPL13a) were the most appropriate internal reference
genes to use in this experiment. All amplified PCR prod-
ucts underwent sequencing (GATC Biotech, Constance,
Germany) to confirm that the correct sequence had been
amplified. Quantitative RT- PCR cycling conditions in-
cluded a 3 min pre-incubation at 95 °C, followed by a
three step amplification program of 40 cycles consisting
of a denaturation, annealing and extension step set at
Table 1 Gene specific primers used for quantitative real-time PCR
Gene Forward primer (5′- 3′) Reverese primer (3′ - 5′) Accession Nr. Amplicon Size (bp)
COL2A1 GCCCAGTTGGGAGTAAGT CACCAGGATTGCCTTGAA NM_001844.4 106
COL1A1 GCTGGTCCTCCAGGTGAA GGGGACCAACAGGACCA NM_000088.3 159
COL10A1 TGGCCTGCCTGACTTTA AATGTCCAGCTCACTGGA NM_000493.3 151
ACAN ACCCAAGGACTGGAATCT CCTGATCCAGGTAGCCTT NM_001135.3 149
COMP TGCACCGACGTCAACGA CCGGGTGTTGATGCACA NM_000095.2 231
SOX9 GTGGCTGTAGTAGGAGCT GCGAACGCACATCAAGA NM_000346.3 155
ACTB (reference) CTGCCCTGAGGCACTC GTGCCAGGGCAGTGAT NM_001101.3 197
RPLP0 (reference) CAACCCAGCTCTGGAGA CAGCTGGCACCTTATTGG BC001834.2 116
TBP (reference) CACTTCGTGCCCGAAAC GCCAGTCTGGACTGTTCT BC110341.1 121
POLR2e (reference) CTATCTGGTGACCCAGGA CTGCAGAAACTGCTCCA J04965.1 322
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95 °C for 10 s, 58 °C for 15 s and 72 °C for 30 s, respect-
ively. Six target genes relative expression between sam-
ples was normalized to the four reference genes using
the qbase+ software (https://www.qbaseplus.com). Data
was further normalized to untreated hADSCs in
monolayer.
Statistics
As described previously [31], data is presented as means ±
standard deviation (SD, n = 9) for the results of WST-1,
PicoGreen and qPCR. Qbase+ software was used to
analyze the data from qPCR. Microsoft Excel and Prism
5.02 software (GraphPad Software, San Diego, USA) were
used for analyzing the data. An ANOVA and a Kruskal-
Wallis test were performed to test for the overall effect of
the variance using R software version 3.6.1 (SAS, Marlow,
UK). The Students T-test was used post hoc for compar-
ing groups of data. A p < 0.05, p < 0.01 and p < 0.001 were
considered significant, highly or extremely significant, re-
spectively. Statistical significance was indicated by * for
p < 0.05, **for p < 0.01 and ***for p < 0.001.
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Additional file 1: Supplementary Figure 1. Immunohistochemical
staining of collagen type I (black arrows, wine red color) at day 7, 14 and
28 in chitosan scaffolds with hADSCs cultured in normal (NS), standard
chondrogenic (CS) or modified chondrogenic + hBMP-6 medium (CS +
hBMP-6). The chitosan scaffolds are a brownish colour, whereas living cell
nuclei and matrix are a pinkish. Magnification set a 10x.
Additional file 2: Supplementary Figure 2. Immunohistochemical
staining of collagen type X at day 7, 14 and 28 in chitosan scaffolds with
hADSCs cultured in normal (NS), standard chondrogenic (CS) or modified
chondrogenic + hBMP-6 medium (CS + hBMP-6). The chitosan scaffolds
are a brownish colour, whereas living cell nuclei and matrix are a pinkish.
Magnification set a 10x.
Additional file 3: Supplementary Figure 3. Relative gene expression
quantity of (A) ACAN, (B) COL1A1, (C) COL2A1, (D) COL10A1, (E) COMP
and (F) SOX9 between all-time points (day 7, 14 and 28) per 3D pellet or
chitosan scaffolds culture medium group (N = normal medium; C = chon-
drogenic medium, P = 3D Pellet; S = chitosan scaffolds,). (*p < 0.05, **p <
0.01, ***p < 0.001). The baseline 0 represents untreated hADSCs in mono-
layer, which was the normalisation factor.
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